SEITO Biologics AG
PrivateLast Round
Early Funding
Jun 3, 2025
Total Funding Raised
$3.44M
Company Overview
SEITO Biologics AG is a biotechnology company that develops targeted cytokine therapies, specifically selective Treg cell engagers (TREX), to restore immune balance in patients with autoimmune and chronic-inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SEITO Biologics AG Comparables
Compare SEITO Biologics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dualyx | 81% | |
| Quell Therapeutics | 78% | |
| Egle Therapeutics | 77% |
SEITO Biologics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 3, 2025 |
SEITO Biologics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lichtsteiner Foundation | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors increased 67% MoM, reaching 2.1K.
- Nov 8, 2025
Monthly visitors increased 65% MoM, reaching 1.3K.
SEITO Biologics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SEITO Biologics AG's valuation, stock price, and market status.
Is SEITO Biologics AG a public or private company?
SEITO Biologics AG is a private company.
What is the current stock price of SEITO Biologics AG?
SEITO Biologics AG is a private company with no public stock price. No recent secondary market data is available.
How much is SEITO Biologics AG worth (valuation)?
Valuation information for SEITO Biologics AG is not publicly available.
Can I buy SEITO Biologics AG stock?
SEITO Biologics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SEITO Biologics AG's last funding round?
SEITO Biologics AG's most recent funding round was Early Funding on June 3, 2025.
Who are the main investors in SEITO Biologics AG?
Key investors in SEITO Biologics AG include Lichtsteiner Foundation.
Will SEITO Biologics AG IPO soon?
No public IPO plans have been announced for SEITO Biologics AG.
How can I track SEITO Biologics AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SEITO Biologics AG's secondary market activity and sign up for updates.